The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Bovaclox DC Xtra

600, 300 mg/syringe Intramammary suspension

Norbrook Laboratories (Ireland) LimitedVPA22664/038/001

Main Information

Trade NameBovaclox DC Xtra
Active SubstancesCloxacillin
Strength600, 300 mg/syringe
Dosage FormIntramammary suspension
Licence HolderNorbrook Laboratories (Ireland) Limited
Licence NumberVPA22664/038/001

Group Information

ATC CodeQJ51CR50 combinations of penicillins
Therapeutic ClassAntibacterial


Licence Issued11/06/1993
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back